Oversea Chinese Banking Corp LTD Abbott Laboratories Transaction History

Oversea Chinese Banking Corp LTD

  • $3.48 Billion
  • Q3 2024

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Apr 29, 2024
BUY
$95.53 - $114.62 $307,893 - $369,420
3,223 New
3,223 $312,000
Q2 2023

Aug 08, 2023
SELL
$100.78 - $112.29 $9,372 - $10,442
-93 Reduced 2.8%
3,223 $351,000
Q1 2023

Sep 15, 2023
SELL
$96.86 - $114.01 $47,751 - $56,206
-493 Reduced 12.94%
3,316 $335,000
Q1 2023

May 08, 2023
SELL
$96.86 - $114.01 $47,751 - $56,206
-493 Reduced 12.94%
3,316 $335,000
Q4 2022

Sep 15, 2023
BUY
$95.06 - $111.52 $55,705 - $65,350
586 Added 18.18%
3,809 $418,000
Q4 2022

Feb 13, 2023
BUY
$95.06 - $111.52 $362,083 - $424,779
3,809 New
3,809 $0

Others Institutions Holding ABT

# of Institutions
3,185
Shares Held
1.3B
Call Options Held
8.74M
Put Options Held
8.08M
View Full List

About ABBOTT LABORATORIES

ABT Quotes by TradingView
  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $208B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Oversea Chinese Banking Corp LTD Portfolio

Follow Oversea Chinese Banking Corp LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Oversea Chinese Banking Corp LTD, based on Form 13F filings with the SEC.

News

Stay updated on Oversea Chinese Banking Corp LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email